U.S. completes withdrawal from the WHO, raising alarms about global health coordination
The United States formally completed its withdrawal from the World Health Organization, a move criticized by global health experts who warn it could weaken disease surveillance and international coordination. Federal officials say the U.S. will pursue global health leadership through alternative partnerships and existing overseas footprints of agencies such as the CDC, NIH, and FDA. Critics counter that leaving the WHO removes a key forum for setting standards and responding quickly to cross-border outbreaks.
- Published
- Updated
Withdrawal becomes official
The United States formally withdrew from the World Health Organization on January 22, 2026, one year after President Donald Trump announced the plan. The exit ends U.S. membership in the 1948-founded global health body and removes the country from a central coordinating institution used to manage outbreaks, share data, and align technical standards across borders.
Administration’s rationale and alternative approach
The Trump administration justified the decision by arguing the WHO mishandled the coronavirus pandemic and failed to adopt reforms, while also citing concerns about political influence. The Department of Health and Human Services said the U.S. intends to remain active in global health through other mechanisms, including bilateral relationships and work conducted by agencies such as the CDC, NIH, and FDA in dozens of countries.
Experts warn about surveillance and preparedness
Public health leaders and infectious-disease experts criticized the withdrawal as a major risk to preparedness, emphasizing that pathogens cross borders regardless of politics. They argue that leaving the WHO can reduce U.S. influence in key technical decisions and diminish channels for rapid information-sharing during fast-moving crises, including seasonal influenza planning and emerging outbreak responses.
What changes immediately—and what remains unclear
Reports indicated U.S. personnel embedded with WHO offices were recalled and U.S. funding was terminated, raising questions about continuity for programs that previously relied on WHO networks. Some obligations and governance questions remain, including financial settlement issues and how the U.S. will participate—if at all—in future WHO-linked coordination mechanisms. The practical impact will depend on what substitute arrangements the U.S. builds and whether other countries treat those alternatives as credible.